Bladder cancer: Clinical practice guidelines in oncology

Peter E. Clark, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff Michalski, Lance C. Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. ShipleyEric J. Small, Philippe E. Spiess, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary Dwyer, Maria Ho

Research output: Contribution to journalArticlepeer-review

272 Scopus citations

Abstract

Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.

Original languageEnglish (US)
Pages (from-to)446-475
Number of pages30
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Bladder cancer: Clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this